rs549476 — NEDD4L

NEDD4L and Salt-Sensitive Blood Pressure — The ENaC Gatekeeper

In the collecting tubule of the kidney, a molecular handshake determines how much salt your body holds onto each day. The epithelial sodium channel (ENaC) sits at the apical membrane of tubular cells and controls the final step of sodium reabsorption. How long ENaC stays at the cell surface — and therefore how much sodium it captures — depends critically on the NEDD4L protein, an E3 ubiquitin ligase that marks ENaC subunits for removal and degradation. Genetic variants in NEDD4L that alter this regulatory efficiency create a spectrum of salt handling phenotypes, with direct consequences for blood pressure and cardiovascular risk. The intronic rs549476 variant lies within this regulatory locus and tags haplotypes associated with altered NEDD4L isoform expression and hypertension susceptibility.

The Mechanism

NEDD4L encodes an HECT-domain E3 ubiquitin ligase¹¹ E3 ubiquitin ligase
An enzyme that attaches ubiquitin tags to target proteins, marking them for proteasomal or lysosomal degradation that specifically targets the β- and γ-subunits of ENaC through their C-terminal PY (proline-tyrosine) motifs. After binding, NEDD4L catalyzes the transfer of ubiquitin chains to ENaC, triggering internalization and degradation of the channel from the cell surface. Less ENaC at the membrane means less sodium reabsorption and, ultimately, lower extracellular fluid volume and blood pressure.

The rs549476 variant is intronic and tags a haplotype that affects NEDD4L isoform balance. The closely linked functional variant rs4149601, at the last nucleotide of exon 1, creates a cryptic splice site²² cryptic splice site
A splice site normally suppressed; when activated by a variant, it causes alternative splicing. The G allele at rs4149601 generates isoform I, which retains the Ca²⁺-dependent lipid-binding C2 domain; this C2-domain-containing isoform interacts less efficiently with ENaC under high-sodium conditions. Carriers of the G haplotype therefore reabsorb more sodium under salt challenge, producing higher blood pressure and greater salt sensitivity³³ salt sensitivity
A blood pressure increase of ≥10 mmHg in response to a sodium load.

The renin-angiotensin-aldosterone system (RAAS) responds by suppressing renin — GG carriers show significantly lower plasma renin concentrations under salt loading, confirming that their kidneys are already retaining excess sodium relative to the system setpoint.

The Evidence

The clinical evidence for NEDD4L variants and salt-sensitive hypertension comes from several independent cohorts. In a Swedish crossover study of 39 normotensive subjects, individuals carrying the high-risk NEDD4L haplotype (GG at rs4149601 plus CC at rs2288774) showed salt sensitivity of 8.0 mmHg versus 5.0 mmHg in non-carriers (P=0.007)⁴⁴ individuals carrying the high-risk NEDD4L haplotype (GG at rs4149601 plus CC at rs2288774) showed salt sensitivity of 8.0 mmHg versus 5.0 mmHg in non-carriers (P=0.007)
Holmberg et al. Polymorphism in NEDD4L is associated with increased salt sensitivity. PLoS One, 2007, with accompanying suppression of plasma renin (9.0 vs 15.0 mU/L, P=0.03) and elevation of N-terminal pro-atrial natriuretic peptide.

The population-scale impact was established in the Malmö Diet and Cancer Study of 27,564 participants⁵⁵ Malmö Diet and Cancer Study of 27,564 participants
Dahlberg et al. Genetic variation in NEDD4L is associated with cardiovascular disease and cardiovascular death. J Hypertens, 2014: carriers of the NEDD4L salt-sensitivity genotype had higher systolic BP (142 vs 141 mmHg, P=0.002) and diastolic BP (86.0 vs 85.6 mmHg, P=0.025), with a multivariate hazard ratio of 1.13 for cardiovascular disease (P=0.018) and 1.20 for coronary events (P=0.005) over 14 years of follow-up.

The pharmacogenomics implications are clinically important. In the PEAR trial of 767 hypertensive patients⁶⁶ PEAR trial of 767 hypertensive patients
Bress et al. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. J Hypertens, 2013, NEDD4L G-allele carriers on hydrochlorothiazide achieved significantly greater blood pressure reductions than non-carriers, consistent with the salt-retaining phenotype being particularly responsive to diuretic therapy.

Practical Actions

The actionable takeaway from the NEDD4L literature is clear: individuals with the salt-retaining genotype benefit disproportionately from sodium restriction and from diuretic antihypertensive therapy. Reducing dietary sodium from a typical 3,400 mg/day to below 1,500 mg/day can lower systolic blood pressure by 5–8 mmHg in salt-sensitive individuals — a reduction comparable to some antihypertensive medications. For those who require pharmacological treatment, thiazide diuretics are particularly effective in this genetic context, and this information should inform antihypertensive prescribing decisions.

Interactions

rs549476 tags a haplotype in LD with the functionally characterized rs4149601 and rs2288774 variants. The combined GG+CC haplotype at these two positions confers the highest salt-sensitivity phenotype, present in approximately 9.6% of European populations.

The NEDD4L pathway also interacts with the alpha-adducin (ADD1 rs4961) and WNK1 variants in a convergent renal sodium-handling network. In a physiological interaction study⁷⁷ In a physiological interaction study
Manunta et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways. Hypertension, 2008, the combination of ADD1 Trp allele plus WNK1 GG plus NEDD4L GA/AA showed consistent synergistic effects on nocturnal blood pressure, thiazide response, and acute saline-challenge BP. Users carrying risk variants in both pathways should be particularly attentive to sodium intake.